SLC25A20 exports excess acyl-CAR

Stable Identifier
R-HSA-9971094
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Mitochondrial carnitine/acylcarnitine carrier protein (SLC25A20, CACT) exports excess acylcarnitines out of mitochondria. This reversed process is possible because the transport mechanism is completely dependent on the concentration gradient of substrates (Schaefer et al., 1997; Ventura et al., 1998).
Literature References
PubMed ID Title Journal Year
9048718 Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy

Schaefer, J, Jackson, S, Taroni, F, Swift, P, Turnbull, DM

J Neurol Neurosurg Psychiatry 1997
9654057 Carnitine palmitoyltransferase II specificity towards beta-oxidation intermediates--evidence for a reverse carnitine cycle in mitochondria

Ventura, FV, Ijlst, L, Ruiter, J, Ofman, R, Costa, CG, Jakobs, C, Duran, M, Tavares de Almeida, I, Bieber, LL, Wanders, RJ

Eur J Biochem 1998
Participants
Participates
Catalyst Activity

carnitine:O-acyl-L-carnitine antiporter activity of SLC25A20 [mitochondrial inner membrane]

Orthologous Events
Cross References
RHEA
Authored
Reviewed
Created
Cite Us!